Harnessing the GLP-1R medicine wave
As a promising treatment for type 2 diabetes and obesity,…
As a promising treatment for type 2 diabetes and obesity, based on key trial data, the market for glucagon-like peptide-1 receptor (GLP-1R) therapies looks set to generate major sales up to 2030.